COVID-19 infection increases risk of stroke and heart attack: Lancet Study Medha Baranwal5 Aug 2021 9:00 AM ISTSweden: COVID-19 may independently increase the risk for ischemic stroke and acute myocardial infarction, a recent study has suggested.The findings,...
Multivessel PCI guided by FFR not superior to angiography for STEMI patients: Study Medha Baranwal21 July 2021 6:15 PM ISTDelhi: A fractional flow reserve (FFR) guided strategy is of no significant benefit over an angiography-guided strategy for STEMI patients undergoing...
Relevance of post-MI use of beta-blockers and MRA, reveals new study Medha Baranwal20 July 2021 9:00 AM ISTUSA: The effects of beta-blocker therapy on survival after myocardial infarction (MI), when analyzed dichotomously, on (all doses) did not demonstrate...
Crushed Prasugrel significantly Lowers Platelet Activity In Patients undergoing PCI: Study MD Bureau6 July 2021 10:30 AM ISTWhen crushed Prasugrel is administered to patients with suspected STEMI, it significantly lowered the platelet activity.
Researchers devise new surgical technique that can repair ruptures caused by heart attack Hina Zahid2 July 2021 9:00 AM ISTThe results showed that the procedure had an impressive 100% success rate. Also, compared to a bleak 10% survival rate if managed conservatively,...
P2Y12 inhibitor monotherapy 3 months after PCI sufficient to lower CV mortality: BMJ Medha Baranwal21 Jun 2021 10:00 AM ISTBern, Switzerland: The use of P2Y12 inhibitor monotherapy versus DAPT is associated with a similar risk of stroke, myocardial infarction, and death,...
High-sensitivity Troponin assays Raise False Alarm In Kidney Impaired Patients Dr Kartikeya Kohli18 Jun 2021 9:00 AM ISTSince 2000, cardiac troponin (cTn) is the preferred biomarker for diagnosis and rule out of acute myocardial infarction (AMI) in patients with healthy...
Periprocedural myocardial injury and MI associated with PCI- Consensus document Medha Baranwal16 Jun 2021 10:30 AM ISTDelhi: The ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) has...
Canagliflozin use does not significantly reduce MI risk in diabetics: Study Medha Baranwal11 Jun 2021 9:00 AM ISTAustralia: The use of SGLT2 inhibitor canagliflozin does not significantly reduce the risk of myocardial infarction (MI) in the population of CANVAS...
Reseachers identify first blood biomarker for myocarditis Hina Zahid28 May 2021 9:53 AM ISTSpain: The human homolog of micro RNA miR-721 could be used for distinguishing patients with myocarditis from those with myocardial infarction,...
One third Patients of ACS potentially eligible for PCSK9 Inhibitors Treatment, finds study MD Bureau19 May 2021 9:00 AM ISTPrevious studies have shown that the PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors evolocumab and alirocumab have been associated...
ARNIs fail to show superiority over ACE-inhibitors in post-MI setting but still give new hope, PARADISE-MI study. dr. Abhimanyu Uppal16 May 2021 11:43 PM ISTAlthough Heart Failure patients have been shown to acquire increased benefit in terms of HF hospitalization and mortality with angiotensin receptor...
